This session will provide updates on anaphylaxis identification and management, specifically discussing the new practice parameters and workgroup report.
Upon completion of this activity, participants should be able to:
- Describe challenges in identifying and managing anaphylaxis
- Discuss updates from the new anaphylaxis practice parameters
- Outline the evidence base for epinephrine in the treatment of anaphylaxis
Roland Solensky, MD FAAAAI
The Corvallis Clinic
Epinephrine for Anaphylaxis: What Do We Know and What Do We Need?
David B. Golden, MD FAAAAI
Johns Hopkins University
Please take a moment to click the link below and give us your feedback on this session: